[EN] NITRONE COMPOUNDS PRODRUGS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME TO TREAT HUMAN DISORDERS [FR] PROMEDICAMENTS A BASE DE COMPOSES NITRONES, ET COMPOSITIONS PHARMACEUTIQUES CORRESPONDANTES PERMETTANT DE TRAITER DES TROUBLES CHEZ L'HOMME
[EN] NITRONE COMPOUNDS PRODRUGS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME TO TREAT HUMAN DISORDERS [FR] PROMEDICAMENTS A BASE DE COMPOSES NITRONES, ET COMPOSITIONS PHARMACEUTIQUES CORRESPONDANTES PERMETTANT DE TRAITER DES TROUBLES CHEZ L'HOMME
Provided are compounds of Formula I:
and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
[EN] CASPASE INHIBITORS CONTAINING ISOXAZOLINE RING<br/>[FR] INHIBITEURS DE CASPASES CONTENANT UN CYCLE ISOXAZOLINIQUE
申请人:LG LIFE SCIENCES LTD
公开号:WO2005021516A1
公开(公告)日:2005-03-10
The present invention relates to an isoxazoline derivative as an inhibitor against various caspases, a process for preparing the same, and a therapeutic composition for preventing inflammation and apoptosis comprising the same
Nitrone compounds, prodrugs and pharmaceuticals compositons of the same to treat human disorders
申请人:Kelly G. Michael
公开号:US20050192281A1
公开(公告)日:2005-09-01
Disclosed are aryl, heteroaromatic and bicyclic aryl nitrone compounds and pharmaceutical compositions containing such derivatives. The disclosed compositions are useful for preventing and/or treating pain, neurodegenerative, autoimmune and inflammatory diseases or conditions in mammals.
The present invention relates to an isoxazoline derivative as an inhibitor against various caspases, a process for preparing the same, and a therapeutic composition for preventing inflammation and apoptosis comprising the same
Bi-functional complexes and methods for making and using such complexes
申请人:Gouliaev Alex Haahr
公开号:US11225655B2
公开(公告)日:2022-01-18
The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.